Bioavailability and pharmacokinetics of intranasal dexmedetomidine in children
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 14 Sep 2017
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Sedation
- Focus Pharmacokinetics
- Acronyms PINDEX
- 11 Sep 2017 Planned End Date changed from 1 Dec 2019 to 31 May 2018.
- 11 Sep 2017 Status changed from not yet recruiting to active, no longer recruiting.
- 09 Nov 2016 New trial record